Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial

Wait 5 sec.

Blood samples from a small lung-disease trial have been run through six independently built ageing clocks, and all six returned the same answer: the patients on the drug looked biologically younger than the patients on placebo. “More lifetimes than humanity lost in all the wars ever fought. If you manage to add 3 years to […]This story continues at The Next Web